MELBOURNE, Fla., Aug. 2 /PRNewswire/ -- Medicomp, Inc., a wholly owned subsidiary of United Therapeutics Corporation, announced today that it has been awarded a contract to sell Ambulatory Holter monitoring systems through Premier Purchasing Partners, L.P.
“Medicomp’s mission has long been to help physicians add quality years to patients’ lives. We are optimistic that this new contract will help even more patients throughout the United States by introducing them to the most advanced Ambulatory Holter monitoring technology available,” said Dan Balda, MD, Medicomp’s President.
Medicomp’s revolutionary Decipher Holter Monitor is designed with an on- board artificial intelligence algorithm, Diogenes(TM), making it capable of detecting a variety of different arrhythmias while on the patient. The Diogenes algorithm has been refined over the last 25 years. As a testament to its quality, Decipher was the only Holter Monitor to pass all the rigorous tests required to monitor the crew of the International Space Station as they live and work in outer space.
About Premier, Inc.
A healthcare alliance entirely owned by more than 200 of the nation’s leading not-for-profit hospitals and healthcare systems, Premier, Inc. helps hospitals accelerate both clinical and financial performance. Premier’s shareholders operate or are affiliated with 1,500 hospitals and more than 41,000 other healthcare sites. Premier’s members and clients benefit from group purchasing and supply chain services, clinical and operational performance measurement, benchmarking and insurance programs. Headquartered in San Diego, CA, Premier has offices in Charlotte, NC, and Washington, DC. For more information, visit http://www.premierinc.com.
About Medicomp, Inc.
Founded in Florida in 1981, Medicomp specializes in providing proprietary cardiac telemedicine services throughout the United States, including 30-day Event Monitoring, Holter Monitoring, and Pacemaker Follow-ups. For more information, visit http://www.medicompinc.com .
United Therapeutics is a biotechnology company which focuses on the development and commercialization of unique products for patients with chronic and life-threatening cardiovascular, cancer, and infectious diseases. For more information, visit http://www.unither.com .
For Further Information, Contact:
Tony Balda, CCT at (321) 676-0010
Email: tbalda@medicompinc.com
Medicomp
CONTACT: Tony Balda, CCT, +1-321-676-0010, or tbalda@medicompinc.com
